Rita Jain is EVP, Chief Medical Officer of ChemoCentryx, Inc.. Currently has a direct ownership of 0 shares of CCXI, which is worth approximately $0. The most recent transaction as insider was on Oct 20, 2022, when has been sold 35,863 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Rita Jain Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 20 2022
SELL
Sale (or disposition) back to the issuer
-
35,863 Reduced 100.0%
0 Common Stock
May 20 2022
BUY
Exercise of conversion of derivative security
-
7,726 Added 17.72%
35,863 Common Stock
Mar 27 2022
BUY
Exercise of conversion of derivative security
-
5,251 Added 15.73%
28,137 Common Stock
May 21 2021
BUY
Exercise of conversion of derivative security
-
4,660 Added 16.92%
22,886 Common Stock
Mar 27 2021
BUY
Exercise of conversion of derivative security
-
5,251 Added 22.37%
18,226 Common Stock

Also insider at

IMVT
Immunovant, Inc. Healthcare
ANAB
ANAPTYSBIO, INC Healthcare
PRVB
Provention Bio, Inc. Healthcare
CLDX
Celldex Therapeutics, Inc. Healthcare
RJ

Rita Jain

EVP, Chief Medical Officer
San Carlos, CA

Track Institutional and Insider Activities on CCXI

Follow ChemoCentryx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCXI shares.

Notify only if

Insider Trading

Get notified when an Chemo Centryx, Inc. insider buys or sells CCXI shares.

Notify only if

News

Receive news related to ChemoCentryx, Inc.

Track Activities on CCXI